You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic CRC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Carcinoma Trial in Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

Recruiting
  • Colorectal Carcinoma
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Mar 23, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (fruquintinib plus TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus TAS-102
  • Guangzhou, Guangdong, China
    the first affiliated hospital of Sun Yat-sen University
Aug 17, 2022

Recurrent and Metastatic CRC After Surgery by Multi-omics

Not yet recruiting
  • Colorectal Cancer Metastatic
  • no intervention
  • (no location specified)
Aug 11, 2022

Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • mCRC
  • Aldoxorubicin Hydrochloride
  • +19 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Duarte, California
  • +6 more
Jan 18, 2023

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Metastatic Colorectal Cancer (CRC) Trial (TRS003, China-approved Bevacizumab, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer (CRC)
  • TRS003
  • +2 more
  • (no location specified)
May 12, 2022

Colorectal Cancer Trial (biological, drug, radiation)

Withdrawn
  • Colorectal Cancer
  • avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • +2 more
  • Duarte, California
  • +2 more
Aug 29, 2022

Colorectal Cancer Metastatic, Peritoneal Carcinomatosis Trial in Amsterdam (Galunisertib plus capecitabine)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Peritoneal Carcinomatosis
  • Galunisertib plus capecitabine
  • Amsterdam, Netherlands
  • +1 more
Jan 17, 2023

Advanced or Metastatic CRC Trial in China (utidelone injection)

Recruiting
  • Advanced or Metastatic CRC
  • utidelone injection
  • Guangzhou, Guangdong, China
  • +4 more
Aug 27, 2021

Colorectal Tumors Malignant Trial in Philadelphia (Axitinib 5 MG, Hydroxychloroquine Pill, trans arterial chemoembolization)

Recruiting
  • Colorectal Neoplasms Malignant
  • Axitinib 5 MG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
May 2, 2022

(CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

Recruiting
  • Colorectal Neoplasms
    • Maastricht, Limburg, Netherlands
      Maastricht UMC+
    Jan 10, 2023

    Colorectal Cancer Metastatic Trial in Phoenix, Jacksonville, Rochester (PolyPEPI1018, Atezolizumab)

    Recruiting
    • Colorectal Cancer Metastatic
    • Phoenix, Arizona
    • +2 more
    Jun 28, 2022

    Metastatic Colorectal Cancer Trial in Hamburg (Avelumab)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Hamburg, Germany
      Universitätsklinikum Hamburg-Eppendorf
    Oct 14, 2021

    Clear Cell Renal Cell Cancer (ccRCC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC) Trial ([68Ga]Ga-DPI-4452,

    Not yet recruiting
    • Clear Cell Renal Cell Cancer (ccRCC)
    • +2 more
    • (no location specified)
    Jan 20, 2023

    Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

    Recruiting
    • Colo-rectal Cancer
    • +2 more
    • mCapOX plus cetuximab
    • mFOLFOX6 plus cetuximab
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Sep 1, 2021

    Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

    Recruiting
    • Non Small Cell Lung Cancer
    • +16 more
    • Goodyear, Arizona
    • +10 more
    Jan 24, 2023

    CRC Trial in Beijing (HL-085, Vemurafenib)

    Not yet recruiting
    • CRC
    • Beijing, Beijing, China
      Beijing Oncology Hospital
    Feb 6, 2022

    5-FU Exposure Optimization in CRC Patients

    Completed
    • Metastatic Colorectal Cancer
    • +2 more
      • La Jolla, California
      • +4 more
      Feb 15, 2022

      Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

      Active, not recruiting
      • Advanced or Metastatic Solid Tumors
      • +8 more
      • Los Angeles, California
      • +5 more
      Nov 29, 2022

      Patients With Advanced Metastatic Colorectal Cancer Trial in Wuhan (Tislelizumab plus Fruquintinib and SBRT)

      Active, not recruiting
      • Patients With Advanced Metastatic Colorectal Cancer
      • Tislelizumab plus Fruquintinib and SBRT
      • Wuhan, Hubei, China
        Huazhong University of Science and Technology
      Aug 15, 2022

      Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma Trial in Rochester

      Recruiting
      • Metastatic Colon Adenocarcinoma
      • +10 more
      • Colorectal Cancer Peptide Vaccine PolyPEPI1018
      • Trifluridine and Tipiracil Hydrochloride
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 10, 2022